BioSpace News Archive

MedHub., a privately held medical device company focused on improving and simplifying cardiac care by replacing risky and costly invasive procedures with AI image-based tools, today announced that the results of the pivotal validation trial of Medhub’s AutocathFFR™ system were accepted as a late-breaking addition to the CRT 2022 conference.

Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a producer and distributor of Chinese herbal medicines, organic agricultural and other biotech products, announced that on February 16, 2022, the Company entered into a strategic cooperation framework agreement (the “Agreement”) with Beijing Jinshengyun Pharmaceutical Technology Co., Ltd. (“JSY”).

23andMe Holding Co. announced that management will be presenting at the Citi 2022 Virtual Healthcare Conference on February 24, 2022 at 1:15 pm Eastern Time.

Edison Oncology Holding Corp. (“Edison Oncology”), today announced, that the first patient has received treatment with Orotecan (irinotecan HCI oral solution) in a Phase I/IIa clinical trial for patients with recurrent pediatric solid tumors.

Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), and its program development partner, EvviVax, S.R.L. (“Evvivax”), today announced the publication of a manuscript detailing a preclinical study (the “study”) showing that LinearDNA™ vaccines used for cancer immunotherapy produced a strong immune and specific antitumoral response in preclinical mouse models.

Discovery Life Sciences™ (Discovery), the biospecimen and biomarker specialists™, today announced the expansion of its GMP-compliant, clinical- grade product portfolio with the launch of Discovery Cryo Leukopaks™ (GMP).

Scientific Industries, Inc., a life sciences tool provider, and a developer of digitally simplified bioprocessing products, yesterday reported financial results for the three and six month periods ended December 31, 2021.

Today hc1, the leader in clinical insight, analytics and solutions for precision health, introduced hc1 Rapid Response Queue™, a new add-on solution for hc1 Operations Management™.

Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be a premium sponsor of the upcoming Molecular Med Tri-Con held February 21-23, 2022 in San Diego, CA

Proxima Clinical Research, a company guiding emerging medical device and pharmaceutical companies from the earliest stages of product development through commercialization, announced it has successfully authored and submitted a 510 for the EvoEndo® Model LE Single-Use Gastroscope, a device that is indicated for both pediatric and adult patients five years and older.